Latest: Watch here for details of new products and services.
- Our Products
- Overview
- Partnering Search
- Company Profiling
- Partneringtools
- Reports
- Partnering Consulting
- Comparison
- Forums
- Visit our forums
- Jobs
- Visit our job site
- Case Studies
- See what others think about our service
- Newsletter
- Partnering update
- Key reports
- Subscribe
- Quick Links
- Profile now
- Register now
- Profiled companies
- Featured events
- Industry news
- PR Newswire New!
- Contact us
- Send an email
- Call us: +44 1904 520460
- Request a callback
- RSS Feeds
- Keep up to date
Pharmalicensing Ltd
is a division of
is a division of
- Out-licensing
- View
Carbonic Anhydrase Inhibiting Agents
Carbonic anhydrase inhibitors available for license.
Full description
Alcon is offering for license: heterocyclic, thiophene, and thienothiadiazine sulfonamides useful as carbonic anhydrase inhibitors.
Development status
Preclinical
Patent information
US5153192 issued 06-Oct-1992 US5240923 issued 31-Aug-1993 US5378703 issued 03-Jan-1995 US5464831 issued 07-Nov-1995 US5510347 issued 23-Apr-1996 US5538966 issued 23-Jul-1996 US5585377 issued 17-Dec-1996 US5646142 issued 08-Jul-1997 US5679670 issued 21-Oct-1997 US5681834 issued 28-Nov-1997
Type of business relationship sought
Available for license.
Licensing contact
Mr. Thomas G. Capetan
Vice President
Licensing / Business Development
Vice President
Licensing / Business Development
Company details
Alcon
Alcon is the worldwide leader in the discovery, development and manufacture of innovative ophthalmic products and technologies.
Alcon is the worldwide leader in the discovery, development and manufacture of innovative ophthalmic products and technologies.
Related reports
Are you looking for reports related to this particular subject. Our Reports section is the best place to start.
Related items
Related categories
© Copyright 1995-2008 Pharmalicensing Ltd, is a division of 
All rights reserved. Terms and Conditions | Site map | Contact us